These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 15894651

  • 1. Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study.
    Cummings SR, Lee JS, Lui LY, Stone K, Ljung BM, Cauleys JA.
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1047-51. PubMed ID: 15894651
    [Abstract] [Full Text] [Related]

  • 2. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.
    J Natl Cancer Inst; 2006 Jan 18; 98(2):110-5. PubMed ID: 16418513
    [Abstract] [Full Text] [Related]

  • 3. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.
    J Natl Cancer Inst; 2004 Dec 15; 96(24):1856-65. PubMed ID: 15601642
    [Abstract] [Full Text] [Related]

  • 4. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.
    J Natl Cancer Inst; 2005 Apr 20; 97(8):595-602. PubMed ID: 15840882
    [Abstract] [Full Text] [Related]

  • 5. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.
    J Natl Cancer Inst; 2006 Oct 04; 98(19):1406-15. PubMed ID: 17018787
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
    Kahán Z, Gardi J, Nyári T, Földesi I, Hajnal-Papp R, Ormándi K, Lázár G, Thurzó L, Schally AV.
    Int J Oncol; 2006 Jul 04; 29(1):193-200. PubMed ID: 16773200
    [Abstract] [Full Text] [Related]

  • 9. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
    Miyoshi Y, Tanji Y, Taguchi T, Tamaki Y, Noguchi S.
    Clin Cancer Res; 2003 Jun 04; 9(6):2229-33. PubMed ID: 12796390
    [Abstract] [Full Text] [Related]

  • 10. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA, Women's Health Initiative Investigators.
    J Natl Cancer Inst; 2007 Nov 21; 99(22):1695-705. PubMed ID: 18000216
    [Abstract] [Full Text] [Related]

  • 11. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec 21; 15(12):2482-8. PubMed ID: 17164374
    [Abstract] [Full Text] [Related]

  • 12. Serum sex hormones and breast cancer risk factors in postmenopausal women.
    Lamar CA, Dorgan JF, Longcope C, Stanczyk FZ, Falk RT, Stephenson HE.
    Cancer Epidemiol Biomarkers Prev; 2003 Apr 21; 12(4):380-3. PubMed ID: 12692114
    [Abstract] [Full Text] [Related]

  • 13. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women.
    Baglietto L, Severi G, English DR, Krishnan K, Hopper JL, McLean C, Morris HA, Tilley WD, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2010 Feb 21; 19(2):492-502. PubMed ID: 20086116
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Risk factors for breast cancer in older women: the relative contribution of bone mineral density and other established risk factors.
    Cauley JA, Song J, Dowsett SA, Mershon JL, Cummings SR.
    Breast Cancer Res Treat; 2007 Apr 21; 102(2):181-8. PubMed ID: 17028986
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
    Bardia A, Hartmann LC, Vachon CM, Vierkant RA, Wang AH, Olson JE, Sellers TA, Cerhan JR.
    Arch Intern Med; 2007 Apr 21; 166(22):2478-83. PubMed ID: 17159013
    [Abstract] [Full Text] [Related]

  • 18. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
    Tworoger SS, Eliassen AH, Sluss P, Hankinson SE.
    J Clin Oncol; 2007 Apr 20; 25(12):1482-8. PubMed ID: 17372279
    [Abstract] [Full Text] [Related]

  • 19. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N.
    J Natl Cancer Inst; 2005 Nov 16; 97(22):1652-62. PubMed ID: 16288118
    [Abstract] [Full Text] [Related]

  • 20. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
    Kennecke H, McArthur H, Olivotto IA, Speers C, Bajdik C, Chia SK, Ellard S, Norris B, Hayes M, Barnett J, Gelmon KA.
    Cancer; 2008 Apr 01; 112(7):1437-44. PubMed ID: 18286526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.